6112
M. Adharvana Chari / Tetrahedron Letters 52 (2011) 6108–6112
1606, 1568, 1528, 1486, 1212, 910, 749 cmÀ1 1H NMR (300 MHz, DMSO-d6): d
;
21. Experimental:
General procedure for synthesis of 3,4-dihydro-quinoxalin-2-amine derivatives: To
1.32 (s, 6H), 3.53 (br s, 1H), 4.64 (br s, 3H), 6.57 (dd, 1H, J = 7.2 and 1.5 Hz),
6.67–6.84 (m, 2H), 7.09 (d, 1H, J = 6.0 Hz), 7.28–7.36 (m, 5H); MALDI-MS: m/z
[M+] = 266; Anal. Calcd for C17H19N3: C, 76.98; H, 7.17; N, 15.85%. Found: C,
76.95, H, 7.15; N, 15.80%. Compound 4k: Off white solid; mp 166–168 °C; IR
a solution of diamine (1 mmol), ketone (1 mmol) and isocyanide (1 mmol) in
3 mL of ethanol was added amberlyst-15(150 mg). The resulting mixture was
stirred for 2–3 h at room temperature. After completion of the reaction, as
indicated by TLC (ethyl acetate/n-hexane 2/1), the catalyst was filtered off and
the product in filtrate was precipitated by the addition of 10 mL of cold water.
The residue was crystallized from ethanol to give 4a–t as solids. All products
were characterized by spectral (IR, NMR & Mass) data and also by the melting
points of the samples. The spectral data of all compounds are given below.
Compound 4a: White solid; mp 218–220 °C; IR (KBr): mmax 3293, 2935, 2861,
(KBr):
m
max 3449, 3397, 3017, 2935, 2856, 1610, 1573, 1525, 1486, 1296, 1242,
;
745 cmÀ1
1H NMR (300 MHz, DMSO-d6): d 1.17–1.25 (m, 1H), 1.36–1.47 (m,
3H), 1.55–1.74 (m, 4H), 1.87(d, 2H, J = 9.0 Hz), 4.19 (s,1H), 4.63 (s, 2H), 4.75(br
s, 1H), 6.64 (dd, 1H, J = 7.2 and 1.8 Hz), 6.75–6.87 (m, 2H), 7.08 (d, 1H,
J = 7.5 Hz), 7.26–7.35 (m, 5H); MALDI-MS: m/z [M+] = 306; Anal. Calcd for
C
20H23N3: C, 78.69; H, 7.54; N, 13.77%. Found: C, 78.65, H, 7.50; N, 13.70%.
Compound 4l: Off white solid; mp 160–162 °C; IR (KBr): max 3276, 2947, 2780,
1656, 1624, 1490, 1455, 1211, 1192, 815, 682 cmÀ1 1HNMR (300 MHz, DMSO-
1642, 1619, 1508, 1455, 1211, 1178, 750, 681 cmÀ1
;
1H NMR (300 MHz, DMSO-
m
d6): d 0.88 (t, J = 3.0 Hz, 3H, –CH2CH3), 1.35 (q, J = 2.8 Hz, 2H, –CH2–), 1.49 (s,
3H, –CH3), 1.11–2.34 (m, 10H, 2 Â 5CH2 of cyclohexyl), 3.99 (br s, 1H, –CH–
NH), 6.31–6.41 (br s, 1H, –NH), 6.70–6.74 (br s, 1H, –NH), 6.78–7.65 (m, 4H, Ar-
H) ppm; MALDI-MS: m/z [M+] = 271; Anal. Calcd for C17H25N3: C, 75.23; H,
9.28; N, 15.48%. Found: C, 75.20; H, 9.24; N, 15.45%. Compound 4b: Off white
;
d6): d 1.92 (s, 3H, –CH3), 2.32 (s, 2H, –CH2 of benzyl isocyanide), 4.03 (br s, 1H, –
NH), 4.93 (br s, 1H, –NH), 6.97–7.83 (m, 14H, Ar-H) ppm; MALDI-MS: m/z
[M+] = 327; Anal. Calcd for C22H21N3: C, 80.70; H, 6.46; N, 12.38%. Found: C,
80.66, H, 6.40, N, 12. 80%. Compound 4m: Pale yellow solid; mp 140–142 °C; IR
(KBr): mmax 3250, 2996, 2850, 1654, 1624, 1489, 1450, 1190, 1160, 815,
solid; mp 148–150 °C; IR (KBr):
mmax 3430, 3265, 2931, 2855, 2354, 1568, 1511,
1311, 1200, 742 cmÀ1 1H NMR (300 MHz, DMSO-d6): d 1.08–1.25 (m, 4H)
;
680 cmÀ1 1H NMR (300 MHz, DMSO-d6): d 1.17 (s, 3H, –CH3), 2.34 (s, 3H, –CH3
;
1.38–1.50 (m, 2H), 1.61–1.78 (m, 10H), 2.02–2.06 (m, 2H), 3.64 (br s, 1H), 4.06
(m, 1H), 4.24 (m, 1H), 6.53 (m, 1H), 6.72–6.80 (m, 2H), 7.01–7.06 (m, 1H);
MALDI-MS: m/z [M+] = 284; Anal. Calcd for C18H25N3: C, 76.33; H, 8.83; N,
14.85%. Found: C, 76.28, H, 8.80; N, 14.83%. Compound 4c: Off white solid; mp
230–232 °C; IR (KBr): mmax 3351, 2935, 2851, 1622, 1541, 1508, 1448, 1314,
of 4-methylacetophenone), 3.56–3.61 (m, 2H, –CH2 of benzyl isocyanide), 4.03
(br s, 1H,–NH), 4.90 (br s, 1H,–NH), 7.12–7.79 (m, 13H, Ar-H) ppm; MALDI-MS:
m/z [M+] = 342; Anal. Calcd for C23H23N3: C, 80.90; H, 6.79; N, 12.31%. Found: C,
80.86; H, 6.70; N, 12.28%. Compound 4n: Pure light gray ash color solid; mp
190–192 °C; IR (KBr): mmax 3261, 2933, 2860, 1640, 1620, 1502, 1455, 1200,
1190, 738, 685 cmÀ1
;
1H NMR (300 MHz, DMSO-d6): d 0.98–1.95 (m, 20H,
1191, 815, 682 cmÀ1 1H NMR (300 MHz, DMSO-d6): d 0.87 (t, J =3.0 Hz, 3H, –
;
2 Â 5CH2 of cyclohexyl), 3.86 (br s, 1H, –CH–NH), 6.69 (br s, 1H, –NH), 6.77 (br
s, 1H, –NH), 7.02–7.46 (m, 4H, Ar-H) ppm; MALDI-MS: m/z [M+] = 297; Anal.
Calcd for C19H27N3: C, 76.72; H, 9.15; N, 14.13%. Found: C, 76.69; H, 9.10, N,
14.10%. Compound 4d: Semi solid; mp 44–46 °C; IR (Neat): mmax 3454, 3046,
CH2CH3), 1.22 (q, J = 2.8 Hz, 2H, –CH2–), 1.50 (s, 3H, –CH3), 1.30–2.33 (m, 10H,
2 Â 5CH2 of cyclohexyl), 3.93–4.04 (br s, 1H, –CH–NH), 6.45–6.56 (br s, 1H, –
NH), 6.72–6.84 (br s, 1H, –NH), 6.89–7.65 (m, 3H, Ar-H) ppm; MALDI-MS: m/z
[M+] = 305; Anal. Calcd for C17H24ClN3: C, 66.76; H, 7.91; N, 13.74%. Found: C,
66.71; H, 7.88, N, 13.70%. Compound 4o: Brown solid; mp 148–150 °C; IR (KBr):
2922, 2855, 2347, 1578, 1506, 1189, 1096, 741 cmÀ1 1H NMR (300 MHz,
;
DMSO-d6): d 1.11–1.26 (m, 4H); 1.41–1.57 (m, 12H), 1.71–1.76 m, 4H), 2.01–
2.04 (m, 2H), 3.82 (br s, 1H), 4.03 (m, 1H), 4.34 (m, 1H), 6.55 (dd, 1H, J = 7.2 and
1.5), 6.70–6.81 (m, 2H), 7.02 (d, 1H, J = 7.2 Hz), MALDI-MS: m/z [M+] = 312;
Anal. Calcd for C20H29N3: C, 77.17; H, 9.32; N, 13.51%. Found: C, 77.15, H, 9.29;
N, 13.50%. Compound 4e: Pale yellow solid; mp 305–307 °C; IR (KBr): mmax
m ;
max 3338, 2929, 2890, 1636, 1619, 1500, 1450, 1198, 1186, 815, 684 cmÀ1 1H
NMR (300 MHz, DMSO-d6): d 0.81–2.32 (m, 20H, 2 Â 5CH2 of cyclohexyl), 3.86
(br s, 1H, –CH–NH), 6.69–6.76 (br s, 1H, –NH), 6.76–6.85 (br s, 1H, –NH), 7.01–
7.52 (m, 3H, Ar-H) ppm; MALDI-MS: m/z [M+] = 331; Anal. Calcd for
C
19H26ClN3: C, 68.76; H, 7.90; N,12.66%. Found: C, 68.69; H, 7.87; N, 12.64%.
Compound 4p: Pale pink solid; mp 245–247 °C; IR (KBr): max 3259, 2938, 2859,
1644, 1619, 1501, 1456, 1212, 1182, 816, 680 cmÀ1 1H NMR (300 MHz, DMSO-
3300, 3252, 2938, 2863, 1649, 1621, 1512, 1462, 1213, 1179, 752, 683 cmÀ1
;
m
1H NMR (300 MHz, DMSO-d6): d 1.06–2.33 (m, 10H, 2 Â 5CH2 of cyclohexyl),
1.89 (s, 3H, –CH3), 4.05 (br s, 1H, –CH–NH), 6.64–6.71 (br s, 1H, –NH), 6.95–
6.99 (br s, 1H, –NH), 7.09–7.67 (m, 9H, Ar-H) ppm; MALDI-MS: m/z [M+] = 319;
Anal. Calcd for C21H25N3: C, 78.96; H, 7.89; N, 13.15%. Found: C, 78.93; H, 7.86;
N, 13.10%. Compound 4f: Pale yellow solid; mp 240 °C; IR (KBr): mmax 3249,
;
d6): d 1.04–2.28 (m, 10H, 2 Â 5CH2 of cyclohexyl), 1.40 (s, 3H, –CH3), 3.92–4.19
(br s, 1H, –CH–NH), 6.70–6.88 (br s, 1H, –NH), 6.88–7.07 (br s, 1H, –NH), 7.08–
7.88 (m, 8H, Ar-H) ppm; MALDI-MS: m/z [M+] = 353; Anal. Calcd for
C
21H24ClN3: C, 71.27; H, 6.84; N, 11.87%. Found: C, 71.23; H, 6.80; N, 11.80%.
Compound 4q: Pale pink solid; mp 258–260 °C; IR (KBr): max 3273, 2923, 2851,
1646, 1625, 1513, 1458, 1401, 1207, 1188, 810, 680 cmÀ1 1H NMR (300 MHz,
2925, 2864, 1647, 1620, 1508, 1397, 1451, 1187, 752, 679 cmÀ1
;
1H NMR
m
(300 MHz, DMSO-d6): d 1.01–2.28 (m, 10H, 2 Â 5CH2 of cyclohexyl), 1.39 (s, 3H,
–CH3), 3.90 (br s, 1H, –CH–NH), 6.52 (br s, 1H, –NH), 6.74 (br s, 1H, –NH), 6.77–
7.51 (m, 8H, Ar-H) ppm; MALDI-MS: m/z [M+] = 334; Anal. Calcd for C21H26N4:
C, 75.41; H, 7.84; N, 16.75%. Found: C, 75.37; H, 7.80; N, 16.70%. Compound 4g:
White solid; mp 262 °C; IR (KBr): mmax 3253, 2937, 2864, 1642, 1620, 1509,
;
DMSO-d6): d 1.04–2.28 (m, 10H, 2 Â 5CH2 of cyclohexyl), 1.40 (s, 3H, –CH3),
3.83–3.94 (br s, 1H, –CH–NH), 6.69–6.74 (br s, 1H, –NH), 6.75–6.78 (br s, 1H, –
NH), 6.78–7.50 (m, 7H, Ar-H) ppm; MALDI-MS: m/z [M+] = 369; Anal. Calcd for
C
21H25ClN4: C, 68.37; H, 6.83; N, 15.19%. Found: C, 68.31; H, 6.80; N, 15.12%.
Compound 4r: Violet solid; mp 218–220 °C; IR (KBr): mmax 3270, 2938, 2864,
1648, 1620, 1503, 1456, 1205, 1185, 815, 680 cmÀ1 1H NMR (300 MHz, DMSO-
1455, 1202, 1190, 753, 680 cmÀ1 1H NMR (300 MHz, DMSO-d6): d 1.00–2.29
;
(m, 10H, 2 Â 5CH2 of cyclohexyl), 1.39 (s, 3H, –CH3), 3.97 (br s, 1H, –CH–NH),
6.53 (br s, 1H, –NH), 6.77 (br s, 1H, –NH), 6.79–7.51 (m, 8H, Ar-H) ppm; MALDI-
MS: m/z [M+] = 398; Anal. Calcd for C21H24BrN3: C, 63.32; H, 6.07; N, 10.55%.
Found: C, 63.28; H, 6.01; N, 10.50%. Compound 4h: White solid; mp 202 °C; IR
(KBr): mmax 3249, 2937, 2858, 1644, 1622, 1508, 1452, 1397, 1204, 1184, 754,
;
d6): d 1.02–2.27 (m, 10H, 2 Â 5CH2 of cyclohexyl), 1.37 (s, 3H, –CH3), 4.01 (br s,
1H, –CH–NH), 6.68–6.74 (br s, 1H, –NH), 6.75–6.81 (br s, 1H, –NH), 6.89–7.57
(m, 7H, Ar-H) ppm; MALDI-MS: m/z [M+] = 432; Anal. Calcd for C21H23BrClN3:
C, 58.28; H, 5.36; N, 9.71%. Found: C, 58.22; H, 5.28; N, 9.65%. Compound 4s:
Brown solid; mp 235–237 °C; IR (KBr): mmax 3272, 2924, 2853, 1647, 1612,
680 cmÀ1
;
1H NMR (300 MHz, DMSO-d6): d 1.05–2.31 (m, 10H, 2 Â 5CH2 of
cyclohexyl) 1.37 (s, 3H, –CH3), 1.38–1.50 (s, 3H, –CH3 of 4-methyl-
acetophenone), 3.89 (br s, 1H, –CH–NH), 6.33–6.41 (br s, 1H, –NH), 6.69–
6.73 (br s, 1H, –NH), 6.73–7.57 (m, 8H, Ar-H) ppm; MALDI-MS: m/z [M+] = 333;
Anal. Calcd for C22H27N3: C, 79.24; H, 8.16; N, 12.60%. Found: C, 79.20; H, 8.12;
N, 12.56%. Compound 4i: White solid; mp 250–252 °C; IR (KBr): mmax 3252,
1513, 1457, 1208, 1188, 810, 680 cmÀ1 1H NMR (300 MHz, DMSO-d6): d 0.98–
;
2.20 (m, 10H, 2 Â 5CH2 of cyclohexyl), 1.37 (s, 3H, –CH3), 2.26 (s, 3H, –CH3 of 4-
methyl acetophenone), 4.00 (br s, 1H, –CH–NH), 6.58–6.74 (br s, 1H, –NH),
6.74–6.77 (br s, 1H, –NH), 6.77–7.49 (m, 7H, Ar) ppm; MALDI-MS: m/z
[M+] = 367; Anal. Calcd for C22H26ClN3: C, 71.82; H, 7.12; N, 11.42%. Found: C,
71.78; H, 7.08; N, 11.36%. Compound 4t: Pale brown solid; mp 258–260 °C; IR
(KBr): mmax 3275, 2925, 2864, 1639, 1629, 1501, 1458, 1401, 1200, 1186, 810,
2925, 2880, 1648, 1622, 1508, 1451, 1209, 1188, 753, 679 cmÀ1 1H NMR
;
(300 MHz, DMSO-d6): d 1.10–2.29 (m, 10H, 2 Â 5CH2 of cyclohexyl), 3.90 (br s,
1H, –CH–NH), 6.50–6.58 (br s, 1H, –NH), 6.74–6.77 (br s, 1H, –NH), 6.78–7.56
(m, 13H, Ar-H) ppm; MALDI-MS: m/z [M+] = 396; Anal. Calcd for C26H28N4: C,
78.75; H, 7.12; N, 14.13%. Found: C, 78.70, H, 7.09; N, 14.10%. Compound 4j: Off
679 cmÀ1
;
1H NMR (DMSO-d6): d 1.14–2.29 (m, 10H, 2 Â 5CH2 of cyclohexyl);
3.87 (br s, 1H, –CH–NH), 6.71–6.74 (br s, 1H, –NH), 6.75–6.78 (br s, 1H, –NH),
6.79–7.52 (m, 12H, Ar-H) ppm; MALDI-MS: m/z = 430; Anal. Calcd for
white solid; mp 151–153 °C; IR (KBr):
mmax 3340, 3294, 3022, 2968, 2925, 2370,
C26H27ClN4: C, 72.46; H, 6.31; N, 13.00%. Found: C, 72.40, H, 6.29, N, 13.05%.